About FDA Guidances

Guidance documents represent the Agency’s current thinking on a particular subject. They do not create or confer any rights for or on any person and do not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statute, regulations, or both. For information on a specific guidance document, please contact the originating office.  Another method of obtaining guidance documents is through the Division of Drug Information.

Find a guidance related to drugs

  • Go to Search for FDA Guidance Documents
  • Scroll down to Guidance Document Search
  • Filter by FDA Organization, Center for Drug Evaluation and Research
  • Use other filters, as needed

TOPICS Related to Drugs
[Terms in brackets are used in the FDA filter dropdown]

  • Administrative/Procedural
  • Advertising
  • Animal Rule
  • Biopharmaceutics
  • Biosimilars
  • Biostatistics
  • Chemistry, Manufacturing, and Controls (CMC)
  • Clinical/Antimicrobial
  • Clinical/Medical
  • Clinical Pharmacology
  • Combination Products
  • Compliance
  • Compounding
  • Current Good Manufacturing Practice (CGMP)
  • Drug Competition Action Plan
  • Drug Development Tools
  • Drug Safety [Safety – Issues, Errors, and Problems]
  • Electronic Submissions
  • FDA Amendments Act (FDAAA)
  • Food and Drug Administration Modernization Act of 1997
  • Generic Drugs
  • ICH-Efficacy
  • ICH-Multidisciplinary
  • ICH-Safety
  • ICH-Quality
  • Labeling
  • Microbiology
  • Over-the-Counter
  • Pharmaceutical Quality 
  • Pharmacology/Toxicology 
  • Product-Specific Guidances for Generic Drug Development (separate database)
  • Rare Diseases
  • Real World Data/Real World Evidence (RWD/RWE)
  • User Fees

Good Guidance Practices

Contact FDA

  • Content current as of:

    03/24/2026

Source

Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting

"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.

Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.